全球預設醫療指示（AD）市場（~2028）：組成部分（軟體/服務）、結構（老年人、中年、年輕）、最終用戶（B2B（醫療保健提供者、保險公司）、B2C）,按地區

預設醫療指示 (AD) 市場規模預計將從 2023 年的 1,229 億美元成長到 2028 年的 2,911 億美元，預測期內年複合成長率為 18.8%。

預測在預測期內，對AD的投資增加以及政府旨在加強患者護理和自主權的舉措和法律規章將為市場提供有利的機會。

從組成部分來看，到 2022 年，部門將佔很大比例。人們越來越認知到預立醫療照護計畫的重要性，以及衛生政策和法律規章對 AD 在減少不必要的干涉和醫療費用以及確保以病人為中心的照護方面的好處的認知。它已經成為。這種認知促使衛生系統將這些服務整合標準實踐，推動該部門的快速成長。

此外，從最終用戶來看，醫療保健提供者部門在 2022 年也佔據了相當大的佔有率。由於醫療保健系統優先考慮以患者為中心的護理和個體化治療，因此醫療保健提供者在發起有關末期病人的意圖、治療選擇和醫療干預措施的對話方面發揮關鍵作用。提供者的專業知識以及與患者的信任關係對於有效引導有關預先護理計劃的敏感討論至關重要。此外，醫療保健提供者採用電子健康記錄(EHR) 和數數位工具正在簡化 AD 的記錄和普及，使患者的偏好更容易獲取和執行。

從地區來看，亞洲預計在預測期內將呈現顯著的成長率。由於反映社會意識不斷發展、醫療保健機會增加以及患者自主意識不斷增強等要素的綜合作用，預計亞洲市場在預測期內將以較高的年複合成長率成長。在該地區，由於高齡化和慢性病增加等人口變化，人們對臨終關懷重要性的認知不斷提高。各國政府和醫療保健組織正在努力克服圍繞死亡和臨終關懷討論的文化禁忌，並促進更公開的對話。此外，醫療保健基礎設施的進步和以患者為中心的護理舉措的興起使 AD 資源更容易獲得。患者希望在醫療決策中擁有發言權，再加上使醫療保健與個人偏好保持一致的配合措施，正在推動亞洲的顯著成長。

該報告調查了全球預先指示（AD）市場，並提供市場概述、市場影響因素和市場機會分析、技術趨勢、案例研究、法律制度、市場規模趨勢和預測以及各種細分。,編制詳細的區域分析、競爭形勢、主要企業簡介等。

目錄

第1章 簡介

第2章 調查方法

第3章 執行摘要

第4章 重要考察

第5章 市場概況

• 市場動態
  • 促進因素
  • 機會
  • 任務
• 產業趨勢
  • ACP 的數位轉型
  • 資料驅動的見解：轉變 ACP
  • 加強 ACP 中的患者參與和個體化護理
• 技術分析
• 波特五力分析
• 法規狀況
• 價值鏈分析
• 生態系/市場地圖
• 專利分析
• 鄰近市場分析
• 案例研究分析
• 主要利害關係人和採購標準
• 重大會議及活動
• 影響買家的趨勢/顛覆

第6章 預立指示 (AD) 市場：依組成部分

• 軟體
• 服務

第7章 預立指示 (AD) 市場：依結構

• 老年組
• 中年
• 年輕人

第8章 預立指示 (AD) 市場：依最終使用者分類

• B2B
• B2C

第9章 預立指示 (AD) 市場：依地區

• 北美洲
• 歐洲
• 亞太地區
• 其他地區

第10章 競爭形勢

• 主要企業/龍頭企業策略
• 市場排名分析
• 企業評價矩陣
• 競爭基準化分析
• 主要企業分析
• 競爭格局及趨勢

第11章公司簡介

• 主要企業
  • ADVAULT, INC.
  • VYNCACARE
  • WISERCARE, INC.
  • IRIS
  • KODA HEALTH
  • THOROUGHCARE, INC.
  • VITAL DECISIONS LLC
  • AFFIRM HEALTH, INC.
  • MIDEO
  • NEW CENTURY HEALTH
  • THANACARE
  • HONOR MY DECISIONS LLC
• NPO
  • SHARP HEALTHCARE
  • ACP DECISIONS
  • BRONSON HEALTHCARE
  • ISLAND HEALTH
  • MUNSON HEALTHCARE

第12章附錄

The advance directives market is projected to reach USD 291.1 billion by 2028 from USD 122.9 billion in 2023, at a CAGR of 18.8% during the forecast period. The rising inestments in advance directives and government initiatives and regulations to enhance patient care and autonomy will provide lucrative opportunities to the market during the forecast period.

"Advance directives services segment accounted for a substantial share of the advance directives market, by component in 2022."

In 2022, the advance directives services segment accounted for a substantial share of the advance directives market. Rising awareness of the importance of proactive healthcare planning, healthcare policies and regulations are increasingly recognizing the benefits of advance directives in terms of reducing unwanted interventions, healthcare costs, and ensuring patient-centered care. This recognition has led healthcare systems to integrate these services into their standard practices, driving the segment's rapid growth.

"Healthcare Providers segment accounted for a considerable share in the advance directives market, by end user in 2022"

In 2022, the healthcare providers segment accounted for a significant share of the advance directives market. As healthcare systems prioritize patient-centered care and personalized treatment, providers play a key role in initiating conversations about end-of-life preferences, treatment options, and medical interventions. Their expertise and trusted relationships with patients position them to effectively navigate sensitive discussions surrounding advance care planning. Moreover, healthcare providers' adoption of electronic health records (EHRs) and digital tools has streamlined the documentation and dissemination of AD documents, enhancing the accessibility and implementation of patient wishes. As a result, the healthcare providers segment stands as a prominent driver of growth within the advance directives market.

"Asia to witness the substantial growth rate during the forecast period."

The Asian market is projected to grow at the high CAGR during the forecast period due to a confluence of factors that reflect evolving societal attitudes, increased healthcare access, and a growing awareness of patient autonomy. As the region undergoes demographic shifts, including an aging population and an increase in chronic diseases, there is a heightened recognition of the importance of end-of-life planning. Governments and healthcare organizations are working to overcome cultural taboos surrounding discussions of death and end-of-life care, fostering a more open dialogue. Additionally, advancements in healthcare infrastructure and a rise in patient-centered care initiatives are facilitating greater access to AD resources. The desire for patients to have a say in their medical decisions, coupled with efforts to align medical care with individual preferences, is propelling the substantial growth of AD in Asia's forecasted years.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players in the Advance directives Solutions Market

The key players operating in the advance directives market include ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US), Bronson Health Care Group, Inc. (US), Koda Health(US), ThroughCare, Inc.(US), Vital Decisions LLC (US), Affirm Health Inc. (US), MIDEO(US), New Century Health (US), Thanacare(US), Island Health(Canada), Honor My Decisions LLC (US).

Research Coverage:

The report analyzes the Advance directives Market and aims to estimate the market size and future growth potential of various market segments, based on components, demographics , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (increasing Investments in advance directives in developed as well as emerging technology adoption, rising demand for personalized care, increasing funding and investments in advance care planning, restraints (lack of awareness and education, communication barrier, opportunities (technological advancement and digital solutions, policy support and legislative framework), and challenges (fragmented healthcare system and lack of indiciplinary collaboration and commiunication) influencing the growth of the advance directives market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the advance directives market.
• Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the advance directives market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the advance directives market like ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US) etc.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH METHODOLOGY STEPS
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 SECONDARY SOURCES
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 PRIMARY SOURCES
    • 2.2.2.2 KEY INSIGHTS FROM PRIMARY SOURCES
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 ASSUMPTIONS FOR THE STUDY
• 2.6 LIMITATIONS
• 2.7 RISK ASSESSMENT
• 2.8 RECESSION IMPACT ON THE ADVANCE DIRECTIVESMARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • DRIVERS
  • RESTRAINTS
  • OPPORTUNITIES
  • CHALLENGES

6 INDUSTRY INSIGHTS

• 6.1 INTRODUCTION
• 6.2 INDUSTRY TRENDS
• 6.3 TECHNOLOGY ANALYSIS
• 6.4 PORTERS FIVE FORCES ANALYSIS
• 6.5 REGULATORY ANALYSIS
  • NORTH AMERICA
  • EUROPE
  • ASIA PACIFIC
• 6.6 VALUE CHAIN ANALYSIS
• 6.7 ECOSYSTEM ANALYSIS
• 6.8 PRICING ANALYSIS
• 6.9 PATENT ANALYSIS
• 6.10 ADJACENT MARKET ANALYSIS
• 6.11 CASE STUDY ANALYSIS
• 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
• 6.13 KEY CONFERENCES AND EVENTS, 2023–2024
• 6.14 TRENDS/DISRUPTIONS IMPACTING BUYERS

7 ADVANCE DIRECTIVES MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 SOFTWARE
• 7.3SERVICES

8 ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS/AGE

• 8.1 INTRODUCTION
• 8.2 ELDERLY POPULATION (65 YEARS AND ABOVE)
• 8.3 MIDDLE-AGED ADULTS (40-64 YEARS)
• 8.4 YOUNG ADULTS (18-39 YEARS)

9 ADVANCE DIRECTIVES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 B2B CONSUMER
  • HEALTHCARE PROVIDERS
  • PAYERS
• 9.3 B2C CONSUMERS
• 9.4 OTHER END USERS

10 ADVANCE DIRECTIVES MARKET, BY REGION

• INTRODUCTION
• NORTH AMERICA
  • US
  • CANADA
• EUROPE
  • GERMANY
  • UK
  • REST OF EUROPE
• ASIA PACIFIC
  • CHINA
  • JAPAN
  • REST OF ASIA PACIFIC
• REST OF THE WORLD

11 COMPETITIVE LANDSCAPES

• OVERVIEW
• STRATEGIES ADOPTED BY KEY PLAYERS
• MARKET RANKING/SHARE ANALYSIS
• COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
• COMPANY FOOTPRINT OF PLAYERS IN ADVANCE DIRECTIVES MARKET
• COMPETITIVE SCENARIO

12 COMPANY PROFILES

• COMPANY PROFILES
  • ADVAULT, INC.
  • VYNCA INC.
  • WISERCARE
  • SHARP HEALTHCARE
  • ACP DECISION (A DBA OF NOUS FOUNDATION, INC.)
  • IRIS (ALEDADE)
  • BRONSON HEALTHCARE
  • KODA HEALTH
  • THOROUGHCARE-
  • VITAL DECISIONS LLC
  • AFFIRM HEALTH
  • MIDEO
  • NEW CENTURY HEALTH
  • VITAS HEALTHCARE
  • THANACARE
  • ISLAND HEALTH
  • HONOR MY DECISIONS

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
• 13.3 AVAILABLE CUSTOMIZATIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS